Showing results (141-150 of 315) with videos related to
Sort By:
Pageof 32
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 19, 2020
Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse after Allogeneic Hematopoietic Stem Cell TransplantationMaria-Luisa Schubert, Sascha Dietrich, Stephan Stilgenbauer, et al.Leukemia & Lymphoma|October 25, 2017
Telomere length in poor-risk chronic lymphocytic leukemia: associations with disease characteristics and outcomeDaniela Steinbrecher, Billy Michael Chelliah Jebaraj, Christof Schneider, et al.Haematologica|October 8, 2008
Autologous stem cell transplantation in elderly patients (> or =60 years) with diffuse large B-cell lymphoma: an analysis based on data in the European Blood and Marrow Transplantation registryEsa Jantunen, Carmen Canals, Alessandro Rambaldi, et al.Bone Marrow Transplantation|September 28, 2019
EASIX and mortality after allogeneic stem cell transplantationThomas Luft, Axel Benner, Tobias Terzer, et al.Blood Advances|June 23, 2023
Comparing the value of mono- vs coculture for high-throughput compound screening in hematological malignanciesSophie A Herbst, Vladislav Kim, Tobias Roider, et al.Journal of Cancer Research and Clinical Oncology|August 31, 2019
Reduced intensity conditioning regimens including alkylating chemotherapy do not alter survival outcomes after allogeneic hematopoietic cell transplantation in chronic lymphocytic leukemia compared to low-intensity non-myeloablative conditioningNiels Smedegaard Andersen, Martin Bornhäuser, Martin Gramatzki, et al.Journal of Clinical Microbiology|October 27, 2012
Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, GermanySteffen Geis, Christiane Prifert, Benedikt Weissbrich, et al.Bone Marrow Transplantation|August 18, 2022
Thiotepa-fludarabine-treosulfan conditioning for 2nd allogeneic HCT from an alternative unrelated donor for patients with AML: a prospective multicenter phase II trialJürgen Finke, Claudia Schmoor, Matthias Stelljes, et al.Ebiomedicine|June 10, 2018
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-ImmunotherapyGeorg Gdynia, Tadeusz Robak, Jürgen Kopitz, et al.British Journal of Haematology|October 10, 2015
Rituximab maintenance improves survival in male patients with diffuse large B-cell lymphoma. Results of the HD2002 prospective multicentre randomized phase III trialMathias Witzens-Harig, Axel Benner, Fabienne McClanahan, et al.Pageof 32